Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis

AIMS: We conducted a systematic review and meta-analysis to assess various antidiabetic agents’ association with mortality in patients with type 2 diabetes (T2DM) who have coronavirus disease 2019 (COVID-19). METHODS: We performed comprehensive literature retrieval from the date of inception until F...

Descripción completa

Detalles Bibliográficos
Autores principales: Kan, Chengxia, Zhang, Yang, Han, Fang, Xu, Qian, Ye, Tongtong, Hou, Ningning, Sun, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481667/
https://www.ncbi.nlm.nih.gov/pubmed/34603199
http://dx.doi.org/10.3389/fendo.2021.708494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481667/
https://www.ncbi.nlm.nih.gov/pubmed/34603199
http://dx.doi.org/10.3389/fendo.2021.708494

Ejemplares similares